Cargando…

Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control

INTRODUCTION: Gestational diabetes mellitus is associated with an increased cardiovascular risk. To better target preventive measures, we performed an in-depth characterization of cardiometabolic risk factors in a cohort of women with gestational diabetes in the early (6–8 weeks) and late (1 year) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosinski, Christophe, Rossel, Jean-Benoît, Gross, Justine, Helbling, Céline, Quansah, Dan Yedu, Collet, Tinh-Hai, Puder, Jardena J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576469/
https://www.ncbi.nlm.nih.gov/pubmed/34750153
http://dx.doi.org/10.1136/bmjdrc-2021-002382
_version_ 1784595882446946304
author Kosinski, Christophe
Rossel, Jean-Benoît
Gross, Justine
Helbling, Céline
Quansah, Dan Yedu
Collet, Tinh-Hai
Puder, Jardena J
author_facet Kosinski, Christophe
Rossel, Jean-Benoît
Gross, Justine
Helbling, Céline
Quansah, Dan Yedu
Collet, Tinh-Hai
Puder, Jardena J
author_sort Kosinski, Christophe
collection PubMed
description INTRODUCTION: Gestational diabetes mellitus is associated with an increased cardiovascular risk. To better target preventive measures, we performed an in-depth characterization of cardiometabolic risk factors in a cohort of women with gestational diabetes in the early (6–8 weeks) and late (1 year) postpartum. RESEARCH DESIGN AND METHODS: Prospective cohort of 622 women followed in a university gestational diabetes clinic between 2011 and 2017. 162 patients who attended the late postpartum visit were analyzed in a nested long-term cohort starting in 2015. Metabolic syndrome (MetS) was based on the International Diabetes Federation definition, and then having at least two additional criteria of the MetS (blood pressure, triglycerides, high-density lipoprotein (HDL) cholesterol, plasma glucose above or below the International Diabetes Federation cut-offs). RESULTS: Compared with prepregnancy, weight retention was 4.8±6.0 kg in the early postpartum, and the prevalence of obesity, pre-diabetes, MetS-body mass index (BMI) and MetS-waist circumference (WC) were 28.8%, 28.9%, 10.3% and 23.8%, respectively. Compared with the early postpartum, weight did not change and waist circumference decreased by 2.6±0.6 cm in the late postpartum. However, the prevalence of obesity, pre-diabetes, MetS-WC and MetS-BMI increased (relative increase: 11% for obesity, 82% for pre-diabetes, 50% for MetS-WC, 100% for MetS-BMI; all p≤0.001). Predictors for obesity were the use of glucose-lowering treatment during pregnancy and the prepregnancy BMI. Predictors for pre-diabetes were the early postpartum fasting glucose value and family history of diabetes. Finally, systolic blood pressure in pregnancy and in the early postpartum, the 2-hour post oral glucose tolerance test glycemia and the HDL-cholesterol predicted the development of MetS (all p<0.05). CONCLUSIONS: The prevalence of metabolic complications increased in the late postpartum, mainly due to an increase in fasting glucose and obesity, although weight did not change. We identified predictors of late postpartum obesity, pre-diabetes and MetS that could lead to high-risk identification and targeted preventions.
format Online
Article
Text
id pubmed-8576469
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85764692021-11-19 Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control Kosinski, Christophe Rossel, Jean-Benoît Gross, Justine Helbling, Céline Quansah, Dan Yedu Collet, Tinh-Hai Puder, Jardena J BMJ Open Diabetes Res Care Cardiovascular and Metabolic Risk INTRODUCTION: Gestational diabetes mellitus is associated with an increased cardiovascular risk. To better target preventive measures, we performed an in-depth characterization of cardiometabolic risk factors in a cohort of women with gestational diabetes in the early (6–8 weeks) and late (1 year) postpartum. RESEARCH DESIGN AND METHODS: Prospective cohort of 622 women followed in a university gestational diabetes clinic between 2011 and 2017. 162 patients who attended the late postpartum visit were analyzed in a nested long-term cohort starting in 2015. Metabolic syndrome (MetS) was based on the International Diabetes Federation definition, and then having at least two additional criteria of the MetS (blood pressure, triglycerides, high-density lipoprotein (HDL) cholesterol, plasma glucose above or below the International Diabetes Federation cut-offs). RESULTS: Compared with prepregnancy, weight retention was 4.8±6.0 kg in the early postpartum, and the prevalence of obesity, pre-diabetes, MetS-body mass index (BMI) and MetS-waist circumference (WC) were 28.8%, 28.9%, 10.3% and 23.8%, respectively. Compared with the early postpartum, weight did not change and waist circumference decreased by 2.6±0.6 cm in the late postpartum. However, the prevalence of obesity, pre-diabetes, MetS-WC and MetS-BMI increased (relative increase: 11% for obesity, 82% for pre-diabetes, 50% for MetS-WC, 100% for MetS-BMI; all p≤0.001). Predictors for obesity were the use of glucose-lowering treatment during pregnancy and the prepregnancy BMI. Predictors for pre-diabetes were the early postpartum fasting glucose value and family history of diabetes. Finally, systolic blood pressure in pregnancy and in the early postpartum, the 2-hour post oral glucose tolerance test glycemia and the HDL-cholesterol predicted the development of MetS (all p<0.05). CONCLUSIONS: The prevalence of metabolic complications increased in the late postpartum, mainly due to an increase in fasting glucose and obesity, although weight did not change. We identified predictors of late postpartum obesity, pre-diabetes and MetS that could lead to high-risk identification and targeted preventions. BMJ Publishing Group 2021-11-08 /pmc/articles/PMC8576469/ /pubmed/34750153 http://dx.doi.org/10.1136/bmjdrc-2021-002382 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Cardiovascular and Metabolic Risk
Kosinski, Christophe
Rossel, Jean-Benoît
Gross, Justine
Helbling, Céline
Quansah, Dan Yedu
Collet, Tinh-Hai
Puder, Jardena J
Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control
title Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control
title_full Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control
title_fullStr Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control
title_full_unstemmed Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control
title_short Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control
title_sort adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control
topic Cardiovascular and Metabolic Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576469/
https://www.ncbi.nlm.nih.gov/pubmed/34750153
http://dx.doi.org/10.1136/bmjdrc-2021-002382
work_keys_str_mv AT kosinskichristophe adversemetabolicoutcomesintheearlyandlatepostpartumaftergestationaldiabetesarebroaderthanglucosecontrol
AT rosseljeanbenoit adversemetabolicoutcomesintheearlyandlatepostpartumaftergestationaldiabetesarebroaderthanglucosecontrol
AT grossjustine adversemetabolicoutcomesintheearlyandlatepostpartumaftergestationaldiabetesarebroaderthanglucosecontrol
AT helblingceline adversemetabolicoutcomesintheearlyandlatepostpartumaftergestationaldiabetesarebroaderthanglucosecontrol
AT quansahdanyedu adversemetabolicoutcomesintheearlyandlatepostpartumaftergestationaldiabetesarebroaderthanglucosecontrol
AT collettinhhai adversemetabolicoutcomesintheearlyandlatepostpartumaftergestationaldiabetesarebroaderthanglucosecontrol
AT puderjardenaj adversemetabolicoutcomesintheearlyandlatepostpartumaftergestationaldiabetesarebroaderthanglucosecontrol